Why the study?
Does human leukocyte and fibroblast interferon inhibit rhinoviruses in vitro?
Does human leukocyte and fibroblast interferon inhibit rhinoviruses in vitro?
Rhinovirus sensitivity to interferon varies widely depending on the cell culture assay system used.
Answers are grounded in this paper and cite their sources.
Assay choice alters apparent rhinovirus interferon sensitivity in vitro; leaves open optimal model for predicting clinical activity.
Rhinoviruses were tested for sensitivity to human interferon from two sources: human leukosytes induced with Sendai virus and human diploid fibroblasts induced with polyriboinosinic-polyribocytidylic acid. Twenty-five serotypes of rhinovirus were tested against fibroblast interferon in HeLa cells, and five serotypes were evaluated in fibroblast cultures against fibroblast and leukocyte interferons. Sensitivity varied widely in the HeLa cell assay; rhinovirus type 10 was inhibited by approximately 20-40 units of interferon, whereas rhinovirus type 15 was not inhibited by 5,120 units; the significance of this observation is unclear. In contrast, when fibroblast cultures were used in the assay system, five selected serotypes, including rhinovirus types 10 and 15, had similar levels of sensitivity (0.5-5.0 units) to fibroblast or leukocyte interferon.
No takes yet. Share an insight, caveat, or question.
Came et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: